Renal Business Today - dialysis, end-stage renal disease (ESRD), home dialysis, chronic kidney disease (CKD), nephrology, Medicare bundle, kidney, dialysis practice management, kidney disease patients

FEATURES

U.S. Renal Care Settles Fraud Case

BALTIMORE—U.S. Renal Care has agreed to pay $7.3 million to the federal government to settle a whistleblower lawsuit brought by a nurse that alleged a company U.S. Renal Care acquired, Dialysis Corporation of America (DCA), ...read more

Travel on Dialysis

“The world is a book, and those who do not travel read only one page,” said Augustine of Hippo. For many, travel provides an expanded world view and a great deal of joy. For many hemodialysis patients, travel seems ...read more

2013 RPA Meeting

If you missed the three-day, 2013 Renal Physician Association conference held in New Orleans, Renal Business Today was there and has the highlights available at your fingertips in the latest digital issue. Renal ...read more

Venous Needle Dislodgement

Venous needle dislodgement (VND) occurs when a venous needle dislodges from a patient's vascular access during hemodialysis treatment. This report discusses VND severity and presents best practices and other solutions to ...read more

A Recipe Guide to Lowering Salt Intake

Whether you are a kidney disease patient or a non-kidney patient, it is important to keep your kidneys as healthy as possible by following a low-sodium diet. Did you know that for a healthy individual over the age of 50, a ...read more

Latest Headlines

TA Associates completes $130 million deal with American Access Care

BOSTON—TA Associates, a private equity firm, has completed a $130 million minority leveraged recapitalization of American Access Care, which operates freestanding outpatient vascular access centers. “We estimate that nationwide more than 90 percent of access procedures are ...More
December 27, 2006
Posted in Articles, Clinical & Pharma
Disaster preparedness 365/24/7

The United States dodged a major bullet this past hurricane season, but that didn’t mean the nation--especially a vulnerable dialysis community--could rest on its laurels and make disaster preparedness a secondary priority. People in Denver can attest to disaster's ...More
December 21, 2006
Posted in Blog
Genzyme files for FDA approval of new phosphate binder

CAMBRIDGE, Mass.--Genzyme Corp. said today it has filed a New Drug Application with the U.S. Food and Drug Administration for its sevelamer carbonate to be used in chronic kidney disease patients on dialysis. ...More
December 21, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
Time for some spring cleaning

Democrats haven't made it a secret that they plan to make health care one of the top issues when Congress goes back to work next month--with drug costs and the uninsured among the top priorities. But rather than focus on old issues with new solutions that may or may not ...More
December 20, 2006
Posted in Blog
Fresenius sells Pharmaplan to Novo Nordisk subsidiary

BAD HOMBURG--Fresenius said today it is selling its subsidiary Pharmaplan to NNE, which is a subsidiary of pharmaceutical company Novo Nordisk. ...More
December 19, 2006
Posted in News, Business
Cantel Medical names new CEO

LITTLE FALLS, N.J.--Cantel Medical Corp. has named former Symphony Health Services chief executive R. Scott Jones as its new president and chief executive officer, the company said today. ...More
December 19, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation
Big issues for the American nephrologist

There is an interesting article in the January 2007 issue of Blood Purification that outlines the major difficulties U.S. nephrologists face in their quest to provide adequate dialysis. Jose A. Diaz-Buxo, MD, FACP, and Terri L. Crawford-Bonadio, RN, CNN--who are both with ...More
December 18, 2006
Posted in Blog
WellBound opens fifth new center in 2006

MOUNTAIN VIEW, Calif.--WellBound said today it has opened a new "Center of Excellence" in Vallejo, Calif., which is the company's fifth new opening in 2006. ...More
December 18, 2006
Posted in News, Business, Clinical & Pharma, Practice Management
FDA gives Roche extension to Mircera review

NUTLEY, N.J.--The U.S. Food and Drug Administration has given Roche a three-month extension to the review period of the anemia treatment Mircera after additional data was submitted to the FDA, according to Roche. ...More
December 15, 2006
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
FDA gives Baxter conditional approval for infusion pump correction plan

DEERFIELD, Ill.-- Baxter Healthcare Corp. said today it has received conditional approval from federal regulators for a corrective action plan for the Colleague Infusion Pump. ...More
December 14, 2006
Posted in News, Business, Government & Regulation, Practice Management